CorMedix Reports Third Quarter 2011 Results

BRIDGEWATER, N.J.--(BUSINESS WIRE)--CorMedix Inc. (“CorMedix”) (NYSE Amex: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of Cardiorenal disease, today announced its results for the third quarter ended September 30, 2011.

MORE ON THIS TOPIC